1. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2. Serrano-Wu, M.; Belema, M.; Synder, L. B.; Meanwell, N.; St. Laurent, D.; Kakaria, R.; Nguyen, V. N.; Qiu, Y.; Yang, X.; Leet, J. E.; Gao, M.; O’Boyle, D. R.; Lemm, J. A.; Yang, F.Inhibitors of HCV Replication. WO 2006/133326 A1, December 14, 2006.
3. Nettles, R. E.; Chien, C.; Chung, E.; Persson, A.; Gao, M.; Belema, M.; Meanwell, N.; DeMicco, M.; Marbury, T.; Goldwater, R.; Northup, P. G.; Coumbis, J.; Kraft, W. K.; Charlton, M.; Lopez-Talavera, J. C.; Grasela, D. M.Poster at theAASLD Liver Meeting, San Francisco, CA, October 31–November 4, 2008.
4. Pack, S. K.; Geng, P.; Smith, M. J.; Hamm, J.Process for Synthesizing Compounds, Useful for Treating Hepatitis C, U.S. Patent 7,728,027 B2, June 1, 2010.
5. Innovative Drug Synthesis